Sequential treatment of advanced or metastatic renal cell carcinoma (mRCC): What is effective? Data from the German RCC registry.
Lothar Mueller
No relevant relationships to disclose
Peter J. Goebell
Honoraria - Bayer; GlaxoSmithKline; Novartis; Pfizer; Roche
A. Lueck
No relevant relationships to disclose
Friedrich Overkamp
No relevant relationships to disclose
Michele Vogt
No relevant relationships to disclose
Norbert Marschner
No relevant relationships to disclose